Healing Shingles Naturally: How East Meets West in Fighting Viral Pain and Brain Risk
Shingles, also known as herpes zoster, is a viral infection that causes a painful, blistering rash and often affects older adults or those with weakened immune systems. But since the COVID-19 pandemic, shingles has been appearing in unexpected age groups—raising new concerns about immunity, stress, and long-term health risks. Without timely treatment, this condition can lead to serious complications, including persistent nerve pain and even cognitive decline.
In an episode of the 'Health 1+1' program, Jonathan Liu, a Canadian professor of Traditional Chinese Medicine, discussed both Western and TCM approaches to treating the infection, along with immune-boosting medicinal recipes that may help reduce the risk of shingles.
The Importance of Early Treatment
The primary treatment for shingles involves antiviral medications such as famciclovir or valacyclovir, which are typically taken orally. In more severe cases, intravenous acyclovir may be used, particularly in hospitalized or immunocompromised patients.
Liu emphasized that early intervention is crucial. Ideally, antiviral therapy should begin before blisters appear. The medication works by suppressing viral replication rather than repairing tissue damage; therefore, starting treatment more than three days after the onset of blisters may significantly reduce their effectiveness.
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
17 minutes ago
- Yahoo
Jack Nathan Health Provides Update on Filing of FY 2024–25 Financial Statements and Audit Progress
TORONTO, June 09, 2025--(BUSINESS WIRE)--Jack Nathan Medical Corp. (TSXV: "JNH"; OTCQB: "JNHMF"), ("Jack Nathan Health", "JNH" or the "Company") announces that it was unable to file its audited consolidated financial statements, management's discussion and analysis (MD&A), and related CEO and CFO certifications for the fiscal year ended January 31, 2025 (collectively, the "Annual Filings") by the required deadline of May 31, 2025. The delay was primarily due to the complexity surrounding the Asset Purchase Agreement (APA) completed on December 1, 2024, under which the Company transferred its Canadian medical clinic business and operations to Well Health Technologies Corp. As part of this transaction, access to EMR systems, supporting documents, and clinical records was also transferred, and this has resulted in extended timelines for data retrieval and audit testing. In addition to the operational handover: The Company underwent a change in external auditors during the fiscal year. A significant number of JNH's employees, including finance and administrative staff, transitioned to Well Health. A resulting delay in commencing the audit, which only began in late February 2025 Despite the late start, Jack Nathan Health made every effort to complete the audit by the filing deadline. Based on that intent, the Company did not apply for a Management Cease Trade Order (MCTO) in advance. However, given the ongoing audit, the Company was unable to meet the statutory filing deadline. As a result, the Ontario Securities Commission issued a Failure-to-File Cease Trade Order ("CTO") against the Company on June 6, 2025, under applicable securities legislation. The CTO prohibits trading in the Company's securities in all Canadian jurisdictions where reciprocal orders apply, until the required filings are completed and the order is revoked. The Company continues to work closely with its auditors to finalize the audit and expects to file well within the 90-day period required for automatic revocation of the CTO. "This past year marked a major transformation for Jack Nathan Health. The transition of our Canadian medical business to Well Health involved an extensive operational and systems handover," said Mike Marchelletta, CEO of Jack Nathan Health. "We recognize the delay in our reporting obligations and remain fully committed to transparency. Our team is working diligently to finalize the audit, and we anticipate filing as soon as possible." About Jack Nathan Medical Corp. Jack Nathan Health® is a provider of MedSpa services in Canada and a former operator of one of the largest retail medical clinic networks in North America. Established in 2006 the Company expanded its international footprint, delivering exceptional, state-of-the-art, turn-key medical centers in 253 locations globally, with 193 corporately owned and operated. In Canada, the Company grew to 82 locations, including 80 clinics in Walmart locations in British Columbia, Alberta, Saskatchewan, Manitoba, Ontario, and Quebec and 2 independent locations, with 22 corporate owned and operated clinics of which 3 included Rehab services and 6 included MedSpa services. In Mexico, the Company grew to 171 corporate owned clinics across Mexico within 3 divisions, including 165 retail clinics, 5 clinics inside Walmart Distribution Centers servicing Walmart Associates, and 1 multidisciplinary clinic. In December 2024, Jack Nathan Health restructured its Canadian medical operations through an asset sale to Well Health Technologies Corp. Following the exit from its Walmart Mexico operations in May 2025, the Company continues to operate its Canadian MedSpa clinics and is actively evaluating strategic opportunities for its future business in Canada, Mexico & USA. For more information, visit or Neither the TSX Venture Exchange nor its Regulation Services Provider (as defined in policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release. Cautionary Note Concerning Going Concern As previously reported by the Company in its consolidated financial statements and related management's discussion and analysis filed on SEDAR+ ( the Company requires additional financing to enable it to continue operations. In the absence of additional financing in the near term, the Company is not expected to have sufficient funds to meet its obligations. The Company is actively pursuing alternatives to raise the necessary additional financing. There can be no assurances that the Company will be able to secure the necessary financing to enable it to continue as a going concern. View source version on Contacts Jack Nathan Medical Corp., Mike Marchelletta, Chief Executive Officer; phone: (647) 488-5008 Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
USA Today
an hour ago
- USA Today
RFK Jr. fires entire CDC vaccine advisory panel
RFK Jr. fires entire CDC vaccine advisory panel Health Secretary Robert F. Kennedy Jr. ousted all 17 members of a panel that advises the CDC on the safety, efficacy and clinical needs of vaccines Show Caption Hide Caption RFK Jr. says COVID-19 vaccine no longer recommended for some The COVID-19 vaccine is no longer recommended for healthy children and pregnant women, HHS Secretary Robert F. Kennedy Jr. says. Health Secretary Robert F. Kennedy Jr. has fired all 17 members of a committee that advises the federal government on vaccine safety and will replace them with new members, the Department of Health and Human Services announced on June 9. At issue is the Advisory Committee for Immunization Practices, which makes recommendations on the safety, efficacy, and clinical need of vaccines to the Centers for Disease Control and Prevention. It comprises medical and public health experts who develop recommendations on the use of vaccines in the civilian population of the United States. 'Today we are prioritizing the restoration of public trust above any specific pro- or anti-vaccine agenda,' said Kennedy Jr., who has a history of controversial views on vaccines. 'The public must know that unbiased science—evaluated through a transparent process and insulated from conflicts of interest—guides the recommendations of our health agencies.' Kennedy Jr.'s decision marks a reversal from what a key Republican senator said the Trump Cabinet member had promised during his confirmation hearings earlier this year. Sen. Bill Cassidy, R-Louisiana, the chair of the Senate Committee on Health, Education, Labor, and Pensions, said Kennedy had promised to maintain the committee's current composition. "If confirmed, he will maintain the Centers for Disease Control and Prevention's Advisory Committee on Immunization Practices without changes," Cassidy said. The Biden administration appointed all 17 sitting committee members, with 13 of them taking their seats in 2024. According to Trump's HHS, those appointments would have prevented the current administration from choosing a majority of the committee until 2028. 'A clean sweep is necessary to reestablish public confidence in vaccine science,' said Kennedy, adding that the new members "will prioritize public health and evidence-based medicine". and "no longer function as a rubber stamp for industry profit-taking agendas."
Axios
an hour ago
- Axios
RFK Jr. removes all 17 members of vaccine committee for CDC
HHS Secretary Robert F. Kennedy on Monday removed all 17 members of the expert panel that makes vaccine policy recommendations to the Centers for Disease Control and Prevention, saying they'd be replaced with "new members currently under consideration." Why it matters: HHS portrayed the unprecedented move as "restoring public trust" in vaccines, but it's expected to introduce anti-vaccine ideology to the influential panel. The big picture: The Advisory Committee for Immunization Practices is comprised of appointees including vaccine and infectious disease experts from academic medical centers and other public health professionals. They evaluate vaccine data at public meetings and were due to meet later this month to discuss COVID-19 vaccines, among other topics. Kennedy during his confirmation process had promised senators he would keep the panel, without committing to maintaining its current makeup. Thirteen of panelists were appointed by the Biden administration in 2024 with terms that end in 2028. "A clean sweep is necessary to reestablish public confidence in vaccine science," Kennedy said in a statement. "ACIP new members will prioritize public health and evidence-based medicine. The committee will no longer function as a rubber stamp for industry profit-taking agendas. The other side:"CDC just lost all credibility in this space," one of the current ACIP members, who requested anonymity in order to comment, told Axios.
